<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药经济报 | wechat-feeds</title><link>http://MjM5MTcyMjYxMw.favicon.privacyhide.com/favicon.ico</link><description>《医药经济报》是国家药品监督管理局南方医药经济研究所主办、全国公开发行的专业报刊，1980年创刊，解读全球产经数据，引领主流思维创新。以办中国最好的专业报为宗旨，旨在成为产业的良心和脑袋，为促进公众健康及医药发展提供智库解决方案。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 23 May 2021 11:49:50 +0800</pubDate><image><url>http://MjM5MTcyMjYxMw.favicon.privacyhide.com/favicon.ico</url><title>医药经济报 | wechat-feeds</title><link>http://MjM5MTcyMjYxMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>疫情下危与机并存 原料药如何强国？</title><link>https://mp.weixin.qq.com/s/57o5vxz_JHSR31rWyajVBg</link><description></description><content:encoded><![CDATA[疫情下危与机并存 原料药如何强国？]]></content:encoded><pubDate>Sun, 23 May 2021 10:49:24 +0800</pubDate></item><item><title>三条线梳理全球再定位</title><link>https://mp.weixin.qq.com/s/tqeyyWfy1ObTP3NGhxxN_Q</link><description></description><content:encoded><![CDATA[三条线梳理全球再定位]]></content:encoded><pubDate>Sun, 23 May 2021 10:49:24 +0800</pubDate></item><item><title>跨越特色原料药第一大国的立项考量</title><link>https://mp.weixin.qq.com/s/GINw2YEL3MQPp8n-7FdUBA</link><description></description><content:encoded><![CDATA[跨越特色原料药第一大国的立项考量]]></content:encoded><pubDate>Sun, 23 May 2021 10:49:24 +0800</pubDate></item><item><title>竞争力加码，转型升级正当时</title><link>https://mp.weixin.qq.com/s/K_kZBCQYwoOZPXUlRfhLNw</link><description></description><content:encoded><![CDATA[竞争力加码，转型升级正当时]]></content:encoded><pubDate>Sun, 23 May 2021 10:49:24 +0800</pubDate></item><item><title>收入利润增幅均超20%，一季度原料药板块成绩喜人</title><link>https://mp.weixin.qq.com/s/7QGwhNrndgfIhCIqqLkY2g</link><description></description><content:encoded><![CDATA[收入利润增幅均超20%，一季度原料药板块成绩喜人]]></content:encoded><pubDate>Sun, 23 May 2021 10:49:24 +0800</pubDate></item><item><title>痛悼！一日双星陨落！</title><link>https://mp.weixin.qq.com/s/mTC-CEyDkxv5a7j998HT7g</link><description></description><content:encoded><![CDATA[痛悼！一日双星陨落！]]></content:encoded><pubDate>Sat, 22 May 2021 17:13:09 +0800</pubDate></item><item><title>国内药企“接盘”诺华、AZ、罗氏重磅原研药，能否再造爆款引擎？</title><link>https://mp.weixin.qq.com/s/6kijapKQajAMX-2IeKco9A</link><description></description><content:encoded><![CDATA[国内药企“接盘”诺华、AZ、罗氏重磅原研药，能否再造爆款引擎？]]></content:encoded><pubDate>Sat, 22 May 2021 17:13:09 +0800</pubDate></item><item><title>e药房 | 降脂药这些不良反应需注意！</title><link>https://mp.weixin.qq.com/s/FIgZWUbBFfW_-UJEPPNBqg</link><description></description><content:encoded><![CDATA[e药房 | 降脂药这些不良反应需注意！]]></content:encoded><pubDate>Sat, 22 May 2021 17:13:09 +0800</pubDate></item><item><title>药明再组百亿基金！新一轮产业投资浪潮到来？</title><link>https://mp.weixin.qq.com/s/TRcqYvdKrJAw5kKn6zzC9A</link><description></description><content:encoded><![CDATA[药明再组百亿基金！新一轮产业投资浪潮到来？]]></content:encoded><pubDate>Fri, 21 May 2021 22:09:06 +0800</pubDate></item><item><title>罗时璋：奏响战略大反攻号角，南京同仁堂启航新征程</title><link>https://mp.weixin.qq.com/s/h1qaMJJ0sFbr94Ph1jQtZw</link><description></description><content:encoded><![CDATA[罗时璋：奏响战略大反攻号角，南京同仁堂启航新征程]]></content:encoded><pubDate>Fri, 21 May 2021 22:09:06 +0800</pubDate></item><item><title>荣研化学LAMP法维权胜诉，创新亟待专利链接保护</title><link>https://mp.weixin.qq.com/s/NZW-dAANNh8V0NzFQraw0A</link><description></description><content:encoded><![CDATA[荣研化学LAMP法维权胜诉，创新亟待专利链接保护]]></content:encoded><pubDate>Fri, 21 May 2021 22:09:06 +0800</pubDate></item><item><title>徐景和一行调研南方所要求：继续开拓进取、扎实工作，迈向崭新发展阶段！</title><link>https://mp.weixin.qq.com/s/-1bSrWTPCkQCJr5EAXgRRQ</link><description></description><content:encoded><![CDATA[徐景和一行调研南方所要求：继续开拓进取、扎实工作，迈向崭新发展阶段！]]></content:encoded><pubDate>Thu, 20 May 2021 20:16:49 +0800</pubDate></item><item><title>弘益药业携手中国药科大学探索中药整体质量研究</title><link>https://mp.weixin.qq.com/s/36aG2g2DQczF-xSk9tCKoQ</link><description></description><content:encoded><![CDATA[弘益药业携手中国药科大学探索中药整体质量研究]]></content:encoded><pubDate>Thu, 20 May 2021 20:16:49 +0800</pubDate></item><item><title>e药房 | 氨氯地平有哪些特点与优势？</title><link>https://mp.weixin.qq.com/s/UQmUwS_GyLVzdUJK61ACjA</link><description></description><content:encoded><![CDATA[e药房 | 氨氯地平有哪些特点与优势？]]></content:encoded><pubDate>Thu, 20 May 2021 20:16:49 +0800</pubDate></item><item><title>广东欲牵头组建全国最大采购联盟！涉及药品超300个？</title><link>https://mp.weixin.qq.com/s/Ziihjns0v8fqyc1uUGv5pA</link><description></description><content:encoded><![CDATA[广东欲牵头组建全国最大采购联盟！涉及药品超300个？]]></content:encoded><pubDate>Wed, 19 May 2021 19:42:44 +0800</pubDate></item><item><title>生物药集采势在必行！两大难点VS五大对策</title><link>https://mp.weixin.qq.com/s/k6aeEYygTFBlpH6E1Wy3Ug</link><description></description><content:encoded><![CDATA[生物药集采势在必行！两大难点VS五大对策]]></content:encoded><pubDate>Wed, 19 May 2021 19:42:44 +0800</pubDate></item><item><title>挖掘院外零售潜力，线上线下掘金正当时</title><link>https://mp.weixin.qq.com/s/s6L6A3jM5RTsB-W-tt-W7g</link><description></description><content:encoded><![CDATA[挖掘院外零售潜力，线上线下掘金正当时]]></content:encoded><pubDate>Tue, 18 May 2021 22:54:44 +0800</pubDate></item><item><title>两大全新采购联盟来了！涉及42个注射剂，短缺药迎机会</title><link>https://mp.weixin.qq.com/s/voU7ruJ-gdwyYHS7sahm1A</link><description></description><content:encoded><![CDATA[两大全新采购联盟来了！涉及42个注射剂，短缺药迎机会]]></content:encoded><pubDate>Tue, 18 May 2021 22:54:44 +0800</pubDate></item><item><title>全球获批抗体药破百！药明、荣昌、科伦、乐普你追我赶，ADC扎堆严重？困局和破局怎解？</title><link>https://mp.weixin.qq.com/s/iah9--zSr_ao926lTNyVkw</link><description></description><content:encoded><![CDATA[全球获批抗体药破百！药明、荣昌、科伦、乐普你追我赶，ADC扎堆严重？困局和破局怎解？]]></content:encoded><pubDate>Mon, 17 May 2021 20:55:47 +0800</pubDate></item><item><title>反垄断重拳出击后，连锁药店入驻电商平台还有哪些挑战？</title><link>https://mp.weixin.qq.com/s/lUSOOcNuYq1eppbTCeT9Xg</link><description></description><content:encoded><![CDATA[反垄断重拳出击后，连锁药店入驻电商平台还有哪些挑战？]]></content:encoded><pubDate>Mon, 17 May 2021 20:55:47 +0800</pubDate></item></channel></rss>